BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 13.09 | -1,872.75 | 11.32 | 7.30 | 13.65 |
What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 13.09 |
| Mar2024 | -1,872.75 |
| Mar2023 | 11.32 |
| Mar2022 | 7.30 |
| Mar2021 | 13.65 |
How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 13.09 | Positive | |
| Mar2024 | -1872.75 | Negative | |
| Mar2023 | 11.32 | 55.07 | |
| Mar2022 | 7.3 | -46.52 | |
| Mar2021 | 13.65 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹138.6 Cr | -9.2% | -24% | -67.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹280,700.0 Cr | -3.9% | -4.6% | -11.6% | Stock Analytics | |
| REDINGTON | ₹21,045.4 Cr | -5.7% | -3.8% | 35.1% | Stock Analytics | |
| MMTC | ₹9,519.0 Cr | -5% | 17.5% | -16.9% | Stock Analytics | |
| HONASA CONSUMER | ₹9,339.7 Cr | -4.3% | 11.9% | 18.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,319.6 Cr | -7.6% | 9.3% | 16.9% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -9.2% |
-24% |
-67.3% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses